The excessive activation of c- KIT or specific mutations in c-KIT have been implicated in a number of human cancers, such as gastrointestinal stromal tumors (GISTs), pancreatic cancer, melanoma and haematological neoplastic diseases [17,18]. Here, KIT is linked to familial pancreatic carcinoma.